News & Events

Pharmacogenomics Company OneOme Announces Patent-Pending Status for RightMed® Test and RightMed Advisor

MINNEAPOLIS (Jan. 10, 2017) – Pharmacogenomics company OneOme today announced the U.S. Patent and Trademark office has issued “Patent Pending” status for its RightMed pharmacogenomic test and RightMed Advisor, an online tool for providers to quickly and easily interpret test results and gain a...


OneOme Receives Laboratory Clinical Certification from Five States

Certification Reaffirms OneOme’s High Standards of Laboratory Quality

MINNEAPOLIS (Jan. 9, 2017) – Twin Cities-based pharmacogenomics company OneOme announced today that it has earned laboratory certification in California, Florida, Maryland, Pennsylvania, and Rhode Island. These certifications affirm OneOme’s commitment to exceeding the specific clinical laborato...


How your DNA has the potential to help you avoid the wrong medications

Did you know more than half of the 4 billion prescriptions written in America this year will not work as intended (IMS, Trends Mol. Med. 2001)? It’s true, and the answer to why that’s the case lies in our DNA.

Individuals respond to medication differently, in large part because everyone’s DNA...


Ridgeview Announces Partnership with Twin Cities-Based OneOme, Provider of RightMed® Test

Patients to Benefit from Personalized Prescription Treatment Options

Waconia, Minn. (Dec. 5, 2016) – Driven to continually improve patient care, Ridgeview Medical Center today announced a partnership with Twin Cities-based pharmacogenomics company OneOme, developer of the RightMed test. Through this partnership, Ridgeview patients will have an opportunity to receiv...


CEOCFO Magazine: Revolutionary prescription writing and ordering portal based on a patient’s genetic profile allows physicians to provide more personalized medications

CEOCFO Magazine, a “weekly publication featuring in-depth interviews with many of today’s top corporate executives,” recently published an interview with Paul Owen, CEO of OneOme.

In the interview Paul discusses the OneOme RightMed® pharmacogenomic test, an analysis of individual patients’...